iSpecimen Inc.
Last updated September 27, 2026
Organization details
- Legal name
- iSpecimen Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 8731 — Services-Commercial Physical & Biological Research
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Woburn
- Headquarters state / province
- Massachusetts
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- ISPC
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001558569
- EIN
- 27-0480143
Board of directors
-
Andrew L. Ross · DirectorSince 2023
-
Arphing Lee · DirectorSince 2025
-
Avtar Dhaliwal · DirectorSince 2024
-
Christopher Ianelli · DirectorSince 2023
-
Elizabeth Ames Graham · DirectorSince 2024
-
George H. Scholl · DirectorSince 2023
-
Jill Mullan · DirectorSince 2023
-
John L. Brooks · DirectorSince 2023
-
Joseph J. Basile · DirectorSince 2023
-
Katharyn Field · DirectorSince 2024
-
Margaret H. Lawrence · DirectorSince 2023
-
Richard Paolone · DirectorSince 2024
-
Robert Bradley Lim · Director · Chief Executive OfficerSince 2024
-
Steven R. Gullans Ph.D. · DirectorSince 2023
-
Theresa L. Mock · DirectorSince 2024
-
Tracy Curley · Director · CEO, CFO and TreasurerSince 2023
Chief executives
Robert Bradley Lim
· Chief Executive Officer
Since December 2024
Tracy Curley
· CEO, CFO and Treasurer
Until December 2024
· Former
Director election results
Annual meeting of July 17, 2024. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
85.8%
-
94.4%
Board connections
3 of this board's directors also sit on 6 other boards.
- via Robert Bradley Lim
- via Katharyn Field
- via Richard Paolone
- via Katharyn Field
- via Richard Paolone
- via Katharyn Field
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 14, 2023 | Bielak Benjamin Officer (Chief Info Officer & Secretary) | Open-market purchase | +18,000 | $0.72 | $12,960 |
| May 31, 2023 | Tracy Curley Director, Officer (CEO, CFO and Treasurer) | Open-market purchase | +4,400 | $1.25 | $5,500 |
| Jan 17, 2023 | Jill Mullan Director | Option exercise | +66,637 | $1.00 | $66,637 |
| Jan 6, 2023 | Christopher Ianelli Director | Option exercise | +845 | $1.00 | $845 |
| Jan 1, 2023 | Joseph J. Basile Director | Grant or award | +63 | — | — |
| Jan 1, 2023 | John L. Brooks Director | Grant or award | +125 | — | — |
| Jan 1, 2023 | Jill Mullan Director | Grant or award | +92 | — | — |
| Jan 1, 2023 | Christopher Ianelli Director | Grant or award | +92 | — | — |
| Jan 1, 2023 | Andrew L. Ross Director | Grant or award | +125 | — | — |
| Jan 1, 2023 | Steven R. Gullans Ph.D. Director | Grant or award | +125 | — | — |
| Oct 1, 2022 | Margaret H. Lawrence Director | Grant or award | +625 | — | — |
| Oct 1, 2022 | George H. Scholl Director | Grant or award | +625 | — | — |
| Oct 1, 2022 | Andrew L. Ross Director | Grant or award | +625 | — | — |
| Oct 1, 2022 | Steven R. Gullans Ph.D. Director | Grant or award | +625 | — | — |
| Oct 1, 2022 | John L. Brooks Director | Grant or award | +625 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.